To offset these potentially confounding variables, we assessed the impact of mutation in a single AML genotype with significant co-occurrence with EZH2, the chromosomal translocation t(8;21) subgroup that rearranges the AML1 and ETO genes. The gene discussed is EZH2; the disease is acute myeloid leukemia.